Current Case Studies
Pediatric subjects ages 3 - 9 with year-round allergies (perennial allergic rhinitis). The study medication involves the investigational use of a currently marketed nasal spray and will consists of 11 visits over a 18 month period. Qualified subjects may be paid for their participation.